Total Payments
$2,784
2024 Payments
$1,218
Companies
23
Transactions
161
Medicare Patients
1,827
Medicare Billing
$139,770
Payment Breakdown by Category
Food & Beverage$2,481 (89.1%)
Education$303.50 (10.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,481 | 157 | 89.1% |
| Education | $303.50 | 4 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $877.36 | 57 | $0 (2024) |
| ABBVIE INC. | $476.38 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $202.78 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $166.42 | 10 | $0 (2024) |
| Madrigal Pharmaceuticals | $133.61 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $124.50 | 7 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $116.91 | 3 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $81.03 | 3 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $71.34 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $63.84 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,218 | 57 | Janssen Biotech, Inc. ($273.54) |
| 2023 | $532.70 | 26 | Janssen Biotech, Inc. ($187.21) |
| 2022 | $580.42 | 51 | Janssen Biotech, Inc. ($189.98) |
| 2021 | $452.99 | 27 | Janssen Biotech, Inc. ($226.63) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: GI | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/01/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/19/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/12/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $89.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 379 | 465 | $80,744 | $29,023 |
| 2022 | 7 | 500 | 599 | $110,822 | $39,798 |
| 2021 | 4 | 480 | 577 | $107,372 | $41,585 |
| 2020 | 6 | 468 | 542 | $87,362 | $29,364 |
Total Patients
1,827
Total Services
2,183
Medicare Billing
$139,770
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 280 | $38,640 | $15,039 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 135 | $27,675 | $10,264 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,932 | $3,136 | 26.3% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 12 | 12 | $2,497 | $584.54 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 232 | 325 | $44,080 | $17,136 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 108 | $21,769 | $8,160 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 61 | $16,492 | $5,724 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $17,244 | $5,089 | 29.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,653 | $1,530 | 32.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 23 | $4,624 | $1,517 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 14 | $1,960 | $640.65 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 287 | $37,869 | $14,875 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 143 | $28,187 | $11,154 | 39.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 89 | 91 | $24,292 | $10,455 | 43.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $17,024 | $5,101 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 188 | 250 | $32,750 | $11,481 | 35.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 95 | $18,715 | $6,629 | 35.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 86 | 86 | $26,144 | $6,563 | 25.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 49 | 50 | $3,300 | $2,018 | 61.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 18 | $4,788 | $1,615 | 33.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 40 | 43 | $1,665 | $1,059 | 63.6% |
About Paula Stultz, ARNP
Paula Stultz, ARNP is a Nurse Practitioner healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164569737.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paula Stultz, ARNP has received a total of $2,784 in payments from pharmaceutical and medical device companies, with $1,218 received in 2024. These payments were reported across 161 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,481).
As a Medicare-enrolled provider, Stultz has provided services to 1,827 Medicare beneficiaries, totaling 2,183 services with total Medicare billing of $139,770. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Cedar Rapids, IA
- Active Since 01/31/2007
- Last Updated 03/11/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1164569737
Products in Payments
- STELARA (Biological) $752.25
- ENTYVIO (Biological) $187.03
- XIFAXAN (Drug) $166.42
- DUPIXENT (Biological) $139.42
- HUMIRA (Biological) $131.72
- RINVOQ (Biological) $128.48
- VOQUEZNA (Drug) $116.91
- REZDIFFRA (Drug) $109.65
- MAVYRET (Drug) $82.46
- REMICADE (Biological) $79.65
- Linzess (Drug) $71.34
- DIFICID (Drug) $63.84
- SKYRIZI (Biological) $63.31
- XELJANZ (Drug) $59.24
- IBSRELA (Drug) $47.84
- VOWST (Biological) $47.55
- OMVOH (Drug) $47.11
- TREMFYA (Drug) $45.46
- ZEPOSIA (Drug) $44.28
- REBYOTA (Biological) $37.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Cedar Rapids
Carla Huber, Arnp, ARNP
Nurse Practitioner — Payments: $17,571
Nurse Practitioner $17,571
Sashi Solomon, Arnp, ARNP
Nurse Practitioner — Payments: $3,452
Nurse Practitioner $3,452
Sarah Norris, Arnp, ARNP
Nurse Practitioner — Payments: $3,114
Nurse Practitioner $3,114
Melissa Coulter, Arnp, ARNP
Nurse Practitioner — Payments: $2,604
Nurse Practitioner $2,604
Dr. Margaret Stracuzzi, Arnp, ARNP
Nurse Practitioner — Payments: $2,523
Nurse Practitioner $2,523
Rikka Burroughs, Arnp, ARNP
Nurse Practitioner — Payments: $2,118
Nurse Practitioner $2,118